Chenyan Gao
Changping, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
The Role and Challenges of Investigator-Initiated Trials in the Cell and Gene Therapy Products Boom in Mainland China.
Journal: Clinical and translational science
Published: November 10, 2024
Highly scalable prefusion-stabilized RSV F vaccine with enhanced immunogenicity and robust protection.
Journal: Nature communications
Published: October 16, 2024
CTR-FAPI PET Enables Precision Management of Medullary Thyroid Carcinoma.
Journal: Cancer discovery
Published: June 26, 2024
Correction to: Shen-Zhi-Ling oral liquid ameliorates cerebral glucose metabolism disorder in early AD via insulin signal transduction pathway in vivo and in vitro.
Journal: Chinese medicine
Published: January 01, 2022
Development and regulation of stem cell-based therapies in China.
Journal: Cell proliferation
Published: October 30, 2021
Shen-Zhi-Ling oral liquid ameliorates cerebral glucose metabolism disorder in early AD via insulin signal transduction pathway in vivo and in vitro.
Journal: Chinese medicine
Published: September 09, 2021
The landscape of CAR T-cell therapy in the United States and China: A comparative analysis.
Journal: International journal of cancer
Published: June 17, 2018
Considerations for Clinical Review of Cellular Therapy Products: Perspectives of the China Food and Drug Administration Center for Drug Evaluation.
Journal: Human gene therapy
Published: February 16, 2018
Showing 1-8 of 8
Last Updated: 09/26/2026